Global Cannabis Company Sells Its European Platform
Portfolio Pulse from Jelena Martinovic
Digicann Ventures Ltd. has sold the shares of AgraFlora Europe GmbH to a third party for €500,000 ($529,675). AgraFlora Europe was established as a platform for the import, storage, and wholesale distribution of cannabis products for medicinal purposes. It held 100% of the shares in Farmako GmbH, Farmako Genetics GmbH, and The Good Company Luxembourg SARL. Farmako and Farmako Limited held various permits and licenses and owned intellectual property related to their business activities.
October 23, 2023 | 7:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Digicann Ventures Ltd. has sold AgraFlora Europe GmbH, which could impact the company's financial position.
The sale of AgraFlora Europe GmbH could impact Digicann Ventures Ltd.'s financial position, but the exact impact will depend on how the company uses the proceeds from the sale.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEUTRAL IMPACT
Digicann Ventures Ltd., listed as CSE:DCNN, has sold AgraFlora Europe GmbH, which could impact the company's financial position.
The sale of AgraFlora Europe GmbH could impact Digicann Ventures Ltd.'s financial position, but the exact impact will depend on how the company uses the proceeds from the sale.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100